Uncategorised - European Medical Journal

The Future of Microbiome-Based Therapeutics

The 32nd United European Gastroenterology Week, held from 12th–15th October 2024 in Vienna, Austria, brought together over 11,500…

Prostate Cancer Playback: Highlights of 2024

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 deaths…

New Horizons for Metachromatic Leukodystrophy

This article summarises an Orchard Therapeutic-sponsored symposium titled ‘New horizons for metachromatic leukodystrophy – with the advent…

Can AI Diagnose Unexplained Fainting?

A machine-learning classifier designed to assist healthcare professionals in accurately diagnosing the causes of transient loss of consciousness (TLOC) has been introduced in a new study.

Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?

Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…

Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis

The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…

Intersection of the Upper Gastrointestinal Microbiome and Oesophageal Cancer

The upper gastrointestinal microbiome, a complex ecosystem of microorganisms that have historically been difficult to identify, may play a…

Infliximab-Induced Multifocal Motor Neuropathy

Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…

Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of weakness affecting…

Pediatric OSA: How Predictive is CPAP Pressure?

Continuous positive airway pressure (CPAP) therapy is a cornerstone in managing severe obstructive sleep apnea (OSA) in children.